Outcomes with Catheter-Directed Thrombolysis versus Mechanical Thrombectomy for Patients with Intermediate/High Risk Pulmonary Embolism: A Meta-Analysis of 24,090 Patients
Abstract
Randomized trials comparing the outcomes with catheter-directed medical thrombolysis (CDT) versus mechanical thrombectomy (MT) for patients with intermediate/high risk pulmonary embolism (PE) are limited. This meta-analysis aimed to assess the clinical outcomes after CDT versus MT for patients with intermediate/high risk PE. Eligible studies compared CDT and MT for patients with intermediate/high risk PE underwent catheter-based therapies were retrieved from a comprehensive literature search for PubMed, Web of Science, Scopus, and Cochrane CENTRAL through June 2026. Outcomes included all-cause mortality, major bleeding, and the length of intensive care unit (ICU) stay. Summary estimates were analyzed using a random effects model. A total of 18 studies (24,090 intermediate/high risk patients) were eligible for the analysis. CDT was associated with longer length of intensive care unit (ICU) stay (mean difference: 1.01 days, 95% confidence interval [CI] 0.87–1.15) compared with MT. While there was no statistical difference between the two groups regarding the risk of all-cause mortality (risk ratio [RR] 0.88, 95% CI 0.76–1.01, p = 0.068) and major bleeding (RR 1.07, 95% CI 0.74–1.55, p = 0.705). Similarly, the incidence of other clinical outcomes; all-cause readmission, PE-related readmission, blood transfusion rates, length of hospital stay, cardiac arrest, and stroke, were similar between the two groups. Among patients with intermediate/high risk PE treated with catheter-based therapies, there was no difference regarding the clinical outcomes between CDT and MT, but CDT was associated with a longer ICU stay. Larger, well designed randomized trials are needed to confirm these findings.